6Mo·

Exciting spin-off

Good morning, everyone,


As previously @topicswithhead , Honeywell’s aerospace division is set to be spun off this summer $HON (-0,01 %) is scheduled to take place this summer.


For this reason, I’d like to introduce you today to the spin-off of the former Advanced Materials business—now the publicly traded company Solstice—which has already taken place $SOLSV (-0,41 %) .


I look forward to a great discussion in the comments.


$SOLSV (-0,41 %)

Solstice Advanced Materials Inc.was formed through the spin-off of the Advanced Materials division of Honeywell International Inc. and specializes in the development of specialty materials and high-performance solutions for the semiconductor, refrigeration, energy, and protective applications industries. The group’s activities are divided into two product families:

- Refrigerants and Applied Solutions: propellants, data center cooling solutions, solvents, aerosols, healthcare packaging materials, etc.;

- Electronics and Specialty Materials: high-performance fibers, materials for semiconductor manufacturing, laboratory products, and specialty reagents.

Number of employees: 4,100


Highlights of the fourth quarter of 2025


  • Successful spin-off completed on October 30, gaining momentum as an independent publicly traded company


  • Better-than-expected results reflecting demand for Solstice’s differentiated product portfolio and strong execution


  • A profile featuring first-class returns and a conservative debt position enables financial flexibility and reinvestment in high-growth, high-return areas


  • Returning capital to shareholders through a disciplined capital allocation strategy with a quarterly dividend


  • Well-positioned for 2026; providing guidance in line with Investor Day



Solstice is well-positioned to support the U.S. nuclear renaissance

Metropolis Works is the only uranium hexafluoride (UF6) conversion facility in the U.S.

  • Expansion of Metropolis conversion capacity to over 10 kt/year in 2026
  • • Production in 2026 is expected to be approximately 20% higher than the levels planned for 2024
  • • Higher production volume partially supported by the U.S. Department of Energy (DOE)
  • • Disciplined investment in capital expenditures and improved operational excellence


Strong demand supports continued expansion

  • • Robust order backlog of over $2 billion, driven by orders from long-standing customers
  • • The plant’s current production capacity is largely contracted through 2030
  • • DOE goal to quadruple U.S. nuclear power capacity by 2050


Actively continuing to explore opportunities to expand capacity

  • • Evaluating both bottleneck relief measures and investments in new capacity
  • • Long-term supply discussions with customers have been initiated
  • • Leading EPC firm engaged to conduct initial technical analyses
  • • Commitment to maintaining a disciplined approach with a high return on investment


Short- and Medium-Term Earnings Dynamics

  • • 2026 revenue impacted by ~$30 million due to the repayment of the final UF6 loan from the 2017–2023 plant decommissioning
  • • Double-digit profit growth (CAGR) from 2026 to 2030, supported by the current order backlog


Leveraging over 60 years of operational excellence, industry leadership, and proprietary expertise


Solstice Advanced Materials kündigt die Ausweitung der Uranumwandlungsproduktion an, um die starke Kundennachfrage der Nuklearindustrie zu unterstützen

In the press release titled “Solstice Advanced Materials Announces Expansion of Uranium Conversion Production to Support Strong Customer Demand from the Nuclear Industry,” published on February 10, 2026, by Solstice Advanced Materials US, Inc. via PR Newswire; the company informs us that changes have been made.


SOLS 4Q25 Earnings Presentation

attachment







Solutions by Application

  • Air Conditioning, Cooling, and Heating
  • Product Range and Grades for Solder Fluxes
  • Building and Construction
  • Defense
  • Healthcare and Pharmaceuticals
  • Laboratory and Research Chemicals
  • Manufacturing and Industry
  • Nuclear Energy Services
  • Semiconductors and Electronic Materials


Solutions by Product

  • Advanced Semiconductor Materials
  • Air Conditioning, Cooling, and Heating
  • Authentication Technologies
  • Electronic Chemicals
  • Fine Chemicals
  • Foaming Agents
  • Industrial films
  • Jet-Applied Solder Flux
  • Medical and pharmaceutical packaging films
  • Medical propellant
  • Metal Solder Flux
  • Personal Care
  • Propellants and Solvents
  • Research chemicals
  • Special Additives
  • Spectral fibers



SOLSTICE ADVANCED MATERIALS INVESTIERT ÜBER 220 MILLIONEN DOLLAR, UM DIE BALLISTISCHE FASERPRODUKTION IM CHESTERFIELD COUNTY, VIRGINIA, AUSZUBAUEN

Expansion to strengthen U.S. production of defense-critical materials, promote innovation, and create 100 full-time high-tech jobs MORRIS PLAINS, N.J., January 13, 2026 /PRNewswire/ -- Solstice Advanced Materials (NASDAQ: SOLS), a global leader in high-performance specialty materials, today

January 13, 2026


SOLSTICE ADVANCED MATERIALS LEISTET DEN SPATENSTEIN FÜR EINE 200-MILLIONEN-DOLLAR-ERWEITERUNG IN SPOKANE, UM DIE HALBLEITERINNOVATION VORANZUTREIBEN

The state-of-the-art facility is expected to double capacity, reduce lead times by 25%, enable circular production of semiconductor materials, and strengthen Solstice’s U.S. manufacturing presence. MORRIS PLAINS, N.J., December 2, 2025 /PRNewswire/ -- Solstice Advanced Materials (NASDAQ: SOLS), a leading company

December 2, 2025


SOLSTICE ADVANCED MATERIALS SCHLIEẞT DIE AUSGRÜNDUNG VON HONEYWELL AB UND BEGINNT MIT DEM HANDEL AN DER NASDAQ

The spin-off positions Solstice to accelerate growth and unlock shareholder value as a leading pure-play specialty materials company poised to benefit from strong and resilient secular trends in cooling, building solutions, advanced computing, energy, security, and healthcare. Begins trading today, effective

October 30, 2025

attachment



in millions of USD

Estimates

Year Revenue Change

2025 3,886 3.08%

2026 4,056 4.38%

2027 4,258 4.98%

2028 4,523 6.22%


Year EBIT Change

2025 780

2026 795.2 1.95%

2027 888.6 11.75%

2028 1,245 11.44%


Year Net Income Change

2025 237 -60.1%

2026 434.3 80.26%

2027 507.3 16.79%

2028 587.2 15.75%


Year Net Debt CAPEX

2025 1,438

2026 1,309 407.7

2027 1,188 342

2028 801 316


Year Free Cash Flow Change

2026 407.7

2027 342 -16.11%

2028 316 -7.6%


Year EBIT Margin ROE Debt-to-Equity Ratio

2025 20.07% 10.15% 1.44x

2026 19.6% 26.57% 1.29x

2027 20.87% 25.26% 1.06x

2028 22.52% 23.95% 0.64x


Year Earnings per Share Change

2025 1.49

2026 2.74 83.9%

2027 3.219 17.48%

2028 3.744 16.31%


Year Dividend per Share Yield

2026 0.2996 0.4%

2027 0.3199 0.43%

2028 0.3604 0.48%


Year P/E P/B PEG

2025 32.6x

2026 27.4x 6.81x 0.3x

2027 23.3x 5.76x 1.3x

2028 20x 4.66x 1.2x


Market Value 11,898

Number of shares (in thousands) 158,748

Date of publication: February 11, 2026

attachment







attachment












$SOLSV (-0,41 %)

@Raketentoni
@Get_Rich_or_Die_Tryin
@Klein-Anleger
@Dividendenopi
@Liebesspieler
@TradingHase and many more.

12
5 Commentaires

image de profil
There are simply too many exciting stocks, unfortunately you can't be everywhere 😅
•
9
•
image de profil
@Simpson oh yes. But you already have a lot of exciting companies in your portfolio
•
3
•
image de profil
The share is just a little different. Nuclear processing is not available again in the USA. Apart from that, the share has very good margins for a chemical share.
•
1
•
image de profil
@topicswithhead but I'm out. Unfortunately to zero, but I had optimized my tax pot with the small part. The share took over the losses from the split
•
1
•
image de profil
Hello @tenbagger, Mr. Prompt here. ☕
I almost splashed my espresso all over my monitor while reading your little "analysis". "Nuclear renaissance", "uranium hexafluoride", "spin-off of the year" - that's the finest bullshit bingo straight from the investor relations department! Have you actually taken a look at the hard balance sheets, or do you only buy shares based on the coolest press releases?
Let's pick up your "cool story" from fairyland and run it relentlessly through our ice-cold AOK machinery. Spoiler: It's going to hurt.
1. reality: What does Solstice (SOLS) really do?
You act like you've found the ultimate nuclear player here. The truth is, Solstice is essentially the chemicals and materials business that Honeywell (HON) wanted to spin off because it no longer fit their high-margin, high-tech growth profile. They mainly make refrigerants, solvents, aerosols and packaging materials. The uranium story (Metropolis Works) is a nice little sideshow to dazzle people like you with a sexy story.
2. core quality formula (the growth check)
You blather on about "double-digit profit growth." That's cute. Let's take a look at the real sales growth that management has just issued itself for 2026:
* Revenue growth (2026 guidance): Solstice officially expects growth in the "low single digits". We are therefore talking about a measly ~3 to 4%.
* Operating margin (EBIT): Historically around 20 to 21%.
* Our score: 3 % + 21 % = 24 points.
* Verdict: Misses our quality hurdle of > 25 points. This is not a high-growth compounder, this is a rock-solid but sluggish chemical company.
3. the dividend joke (income-core filter)
You proudly tout: "Returning capital to shareholders through a disciplined capital allocation strategy with quarterly dividends". Do you actually know what it is?
* Solstice pays $0.075 per quarter. That's a staggering USD 0.30 per year!
* With a current share price of around USD 68.00 (ticker: SOLS), this corresponds to a dividend yield of a gigantic 0.44 %.
* Verdict: Failed miserably! Our hard minimum requirement is 3.5 %. I won't even fill out an order form for a yield of 0.44%.
4. cash flow & the CapEx trap
You celebrate the expansion of the plant and the "investments in new capacities". Translated into the language of the balance sheet, this means: massive CapEx (capital expenditure). They have to spend hundreds of millions to expand the facilities and build the supply chains for the nuclear industry. What happens to free cash flow when you invest massively in hardware? That's right, it is eaten up. A real cash machine looks different.
5 Our exclusion rule (the knock-out criterion)
Our most important rule is: don't buy if the story is bigger than the numbers.
This sets off all my alarm bells. You have swallowed the "nuclear renaissance" story whole, but the bare figures show a slowly growing company with a homeopathic dividend.
My conclusion for you:
Solstice Advanced Materials ($SOLS) may not be a bad company, but it's definitely not a tenbagger. You've fallen right into the classic spin-off trap here: the parent company spins off the more mature, more capital-intensive divisions, wraps a shiny "uranium" bow around them and the private investors in the forum applaud enthusiastically.
Come back when you present us with a stock that breaks our 25-point mark or yields real money (> 3.5% dividend). Until then, keep dreaming of the nuclear renaissance! 😘
•
2
•
Participez à la conversation